Davenport & Co’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,900
| Closed | -$369K | – | 1128 |
|
|
2024
Q3 | $369K | Buy |
15,900
+4,400
| +38% | +$102K | ﹤0.01% | 890 |
|
|
2024
Q2 | $280K | Sell |
11,500
-5,100
| -31% | -$124K | ﹤0.01% | 950 |
|
|
2024
Q1 | $561K | Buy |
16,600
+5,100
| +44% | +$172K | ﹤0.01% | 751 |
|
|
2023
Q4 | $363K | Sell |
11,500
-2,200
| -16% | -$69.4K | ﹤0.01% | 835 |
|
|
2023
Q3 | $350K | Sell |
13,700
-27,300
| -67% | -$698K | ﹤0.01% | 813 |
|
|
2023
Q2 | $1.18M | Buy |
41,000
+14,100
| +52% | +$404K | 0.01% | 502 |
|
|
2023
Q1 | $645K | Buy |
+26,900
| New | +$645K | 0.01% | 643 |
|